ACT Brief: AI Governance Lag, Site Payment Experience, and Schizophrenia Relapse Prevention

In today's ACT Brief, we examine governance inertia when AI accelerates protocol development, why payment experience is becoming a competitive differentiator for sites, and FDA approval of Caplyta for relapse prevention in schizophrenia.